Julie Johnson is not exactly dominating the news cycle right now. Zero Google News stories in the last 24 hours. Three posts on Bluesky, one of which appears to be a Brazilian ebook promotion that tagged her name by accident. The social conversation that does exist is pointed: LGBTQ+ advocates are calling out co-chairs of the Equality Caucus, Johnson included, for being absent when it counted on a recent House vote. On the financial disclosure side, there's a smaller but tidier story: two sales, one day, two tickers, both of which outperformed the S&P 500 over the following 30 days.
The Equality Caucus Problem
The criticism circulating online centers on HR 2616 and the perception that members of the House Equality Caucus — whose entire brand is showing up for LGBTQ+ constituents — didn't. Johnson is named alongside fellow co-chair Angie Craig as members who "couldn't bother" to act when other caucus members were voting in ways advocates found objectionable.
That's a political problem, not a financial one. It illustrates a recurring tension for members who hold caucus leadership titles: the title creates accountability expectations the floor vote record has to actually satisfy.
Per the roll call, Johnson voted Nay on the Veterans 2nd Amendment Protection Act on May 21 and recorded two "Not Voting" entries the same week — on the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act and the Fiscal Year 2025 VA Major Medical Facility Authorization Act. None of those bills fall within the remit of her committees, which run through Foreign Affairs, Homeland Security, and House Administration. They're floor votes. Three absences or dissents in a single week is a pattern that opponents and frustrated allies alike will clip.
The Two Trades
On May 12, 2026, Johnson's disclosure record shows two sales filed on the same date.
Sale one: Abbott Laboratories (ABT), in the $1,001 to $15,000 range. Sale two: Accenture (ACN), same range, same day.
The disclosure window under the STOCK Act allows members 45 days to report a trade after it executes. The May 12 date is the trade date as disclosed, not the filing date. Both sales were in the smallest reportable band, so the dollar precision ends there.
The alpha record shows 2 trades scored, 2 positive outcomes, 0 negative. Mean 30-day alpha versus the S&P 500: 1.3 percent. The ACN sale logged 2.3 percent alpha in the 30 days following the trade. The ABT sale logged 0.2 percent. Both on the same day, both sales, both outperforming the index.
Two trades is a sample size that proves nothing about skill and proves nothing about luck. The alpha record here is the full scored sample, not a highlight reel. There are no losing trades in the record because there are only two trades in the record.
What Johnson Sits On
Johnson's committee assignments are Foreign Affairs, Homeland Security, and House Administration, with subcommittees covering Europe, South and Central Asia, Border Security, Emergency Management, Elections, and the Joint Committee on the Library.
Abbott makes medical devices and diagnostics. Accenture does IT consulting and outsourcing. The Venn diagram between "House Foreign Affairs" and "medical devices" has some overlap in theory — mostly in the global health policy neighborhood — but nothing in the disclosed trades flags a direct committee jurisdiction match. The alpha record confirms: committee overlap on both trades is listed as null.
A trade with no committee overlap is just a trade.
The Votes That Are Actually in Her Lane
Johnson's recent vote record includes two bills with genuine market relevance that sit closer to her committee world.
On June 29, she voted Yea on the TRIA Program Reauthorization Act of 2026, which extends the federal terrorism risk insurance backstop. TRIA affects insurers, reinsurers, and commercial real estate broadly. Johnson's committees touch Homeland Security, and terrorism risk is at least adjacent to the emergency management subcommittee she sits on.
On June 25, she voted Yea on the Financial Exploitation Prevention Act of 2025, which targets financial fraud against seniors and vulnerable adults. Her committees don't include Financial Services, so there's no oversight angle. It's a floor vote.
Neither bill overlaps with her May 12 trades in any way the data flags. The vote-trade overlap table for Johnson is empty.
The Calendar, for the Record
The trades were filed May 12. The two veterans bills where she recorded "Not Voting" came May 20 and 21. The TRIA and Financial Exploitation votes came in late June, six weeks after the trades cleared.
No flagged timing coincidence. The filings show a member who sold two mid-cap positions in May and then voted on a series of floor bills over the following weeks — none of which connect to those tickers in a documented way.
Abbott and Accenture: Why Sell in May?
Abbott Laboratories is a healthcare conglomerate with a medical device and diagnostics core — a defensive holding, the kind of name that shows up in congressional portfolios because it's boring in a reassuring way. Accenture is a global consulting and technology services firm with heavy federal government contracting exposure.
Both are large-cap, liquid, widely held. Selling them in the $1,001 to $15,000 range is trimming, not an exit. The disclosure rules don't require a reason, so there's not one on the record. Both positions lost ground relative to the S&P 500 in the 30 days after the sale date — the timing, on paper, was clean.
A member sold two positions, the market moved in a direction that made the sales look good in hindsight, and that's the extent of what the public record establishes.
What Members Are Required to Do
Members are required to disclose. They are not required to divest, recuse, abstain, or explain themselves in any filing. The STOCK Act created the disclosure infrastructure. It did not create a prohibition on holding or trading stocks in sectors touched by legislation members vote on.
Johnson's full disclosure record is public. Two trades in 90 days is a light footprint compared to members who file dozens of transactions per quarter. The record here is short, the alpha is positive, the committee overlap is zero, and the political heat she's drawing right now has nothing to do with any of it.
The receipts are public. Make of them what you make of them.